Source link : https://www.newshealth.biz/health-news/how-to-stop-bone-loss-after-denosumab-no-easy-answers/
Patients who discontinue treatment with the osteoporosis drug denosumab, despite transitioning to zoledronate, show significant losses in lumbar spine bone mineral density (BMD) within a year, according to the latest findings to show that the rapid rebound of bone loss after denosumab discontinuation is not easily prevented with other therapies — even bisphosphonates. “When initiating […]
Author : News Health
Publish date : 2024-11-21 12:52:04
Copyright for syndicated content belongs to the linked Source.